Let’s face it, when it comes to taking medicine, taste is usually the last thing on our minds. We’re more concerned about whether it works, has any side-effects or how it might interact with other medications. But for some folks, the bitter taste of certain drugs can be a real deal-breaker.
Imagine trying to swallow something that tastes awful every day! Luckily, there’s some fascinating research suggesting a clever solution to this problem.
A recent study published in Clinical Therapeutics by a team from the Monell Chemical Senses Centre sheds light on this issue. They discovered that a diabetes drug called rosiglitazone could actually help mask the bitter taste of some medications. It’s like adding a little sugar to bitter coffee to make it more palatable.
The researchers found that rosiglitazone, when added in small doses to other medicines, could reduce their bitterness, making them easier to swallow. What’s particularly interesting is that this effect was identified using tests on human cells from taste tissue, a method developed by Monell and DiscoveryBiomed, Inc. This means they didn’t have to rely on taste tests alone – they could see how the drug affected taste at a cellular level.
But here’s the kicker: Rosiglitazone isn’t your typical bitter blocker. In fact, this study marks the first time it’s been identified as having this effect. Lead author Ha Nguyen, PhD, a Monell Postdoctoral Fellow, expressed surprise at the discovery, noting that previous reports hadn’t mentioned rosiglitazone’s potential as a bitter blocker.
To unravel this mystery, the researchers conducted taste-testing experiments on participants from the US and Poland. They found that while adding rosiglitazone did reduce bitterness for many participants, it didn’t work for everyone. This variability highlights the complexity of taste perception and the need for further research to understand why some people are more sensitive to bitterness than others.
Senior author Danielle Reed, PhD, Monell’s Chief Science Officer, emphasised the importance of testing these solutions on diverse populations. People from different parts of the world may have different sensitivities to taste, so it’s crucial to ensure that any efforts to reduce bitterness work for everyone.
But the story doesn’t end there. The researchers believe that rosiglitazone is just the tip of the iceberg when it comes to bitter-blocking potential. They envision a future where multiple blockers could be combined to completely suppress the bitterness of even the most unpleasant-tasting medicines.
“Mixtures of several blockers may help attain a low-to-zero-bitterness standard for even the most bitter-tasting medicines,” said Nguyen. “Although rosiglitazone was only partially effective as a bitter blocker in this study, modifying these drugs to improve potency, palatability, and efficacy may allow us to find a better version of this drug.”
‘From Bitter to Better’ sounds like a catchy title for the journey of improving medicine taste! So, while we may not be able to make bitter medicine taste like candy just yet, research like this brings us one step closer. Who knows, maybe one day we’ll have a pill that tastes so good, we’ll forget we’re even taking medicine! And perhaps we’ll be asking for the caramel flavour pill with a side of vanilla oral suspension!
Here’s to the scientists working hard to make our meds a little easier to swallow. Cheers!
ammar.shakr@gmail.com
&uuid=(email))